Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

AGC Biologics collaborates with Molecular Partners AG to develop the DARPin® anti-COVID-19 program

Saturday, July 11, 2020

Leading global company specializing in contract manufacturing and development CDMO AGC Biologics has partnered with clinical stage biotechnology company Molecular Partners AG to develop a new class of proteinbased therapeutic products that are cust...

ProteinQure collaborates with AstraZeneca to develop new therapeutic peptides

Friday, July 10, 2020

ProteinQure a leader in computer discovery of proteinbased drugs announces that it will collaborate with global biopharmaceutical company AstraZeneca to apply a structurebased design method to creation of therapeutic libraries in order to accelerate...

Kymera Therapeutics And Sanofi Enter Into Strategic Partnership To Advance Novel Protein Degrader Therapies To Patients

Friday, July 10, 2020

Kymera Therapeutics Inc today announced the company has entered into a multiprogram strategic collaboration with Sanofi to develop and commercialize firstinclass protein degrader therapies targeting IRAK in patients with immuneinflammatory diseases

Zymeworks Announces New Multispecific Antibody Collaboration with Merck

Thursday, July 09, 2020

Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional biotherapeutics announced that it and longtime partner Merck known as MSD outside the US and Canada have signed a new license agreement granting Merck the right to dev...

Xencor and Atreca Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies

Thursday, July 09, 2020

Xencor Inc a clinicalstage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases and Atreca Inc a clinicalstage biotechnology company focused on developing novel therapeutics generat...

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China

Wednesday, July 08, 2020

Turning Point Therapeutics Inc a precision oncology company developing nextgeneration therapies that target genetic drivers of cancer and Zai Lab an innovative commercialstage biopharmaceutical company today announced an exclusive license agreement f...

Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases

Wednesday, July 08, 2020

Boehringer Ingelheim and Numab Therapeutics Numab today announced that they have entered into a research collaboration and worldwide licensing agreement It will start with two projects aiming at novel therapies for difficulttotreat lung and gastroint...

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

Tuesday, July 07, 2020

Unum Therapeutics Inc a biopharmaceutical company focused on developing therapies for solid tumors today announced it has completed the acquisition of Kiq LLC Kiq a privately held biotechnology company focused on the discovery and development of prec...

Ascentage Pharma Announces Clinical Trial Collaboration Agreement with MSD to Evaluate APG-115

Tuesday, July 07, 2020

Ascentage Pharma HK a global clinicalstage biotechnology company developing novel therapies for cancers chronic hepatitis B CHB and senesce diseases announced a clinical collaboration with MSD to evaluate the combination of APG Ascentages MDMp inhibi...

HitGen and Morphic Extend Drug Discovery Research Collaboration

Monday, July 06, 2020

HitGen Inc announced that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against targets specified by Morphic HitGens industryleading DNAencoded library DEL technology platfor...